商铺首页
公司详情
产品陈列室
公司动态
联系方式
基本信息
企业名称
安徽奇奥医药科技有限公司
企业地址
安徽省合肥市安徽省合肥市肥西县经济开发区汤口路与汤家汇路交口运河产投企业港F12
成立日期
2015
企业规模(人)
10人以下
年销售额(USD)
不愿意公开
企业简介
安徽奇奥医药科技有限公司成立于2015年,公司经过不断锐意进取,目前已发展成为集化学、生物药物研究,医药中间体、原料药,制剂和产品销售于一体的高新技术医药企业。通过在成品药、原料药和中间体等医药健康领域的贸易与创新,以世界合成化工的发展趋势为导向,不断开发出国内外的新优势品种,目前主要销售市场是韩国、印度、巴基斯坦、孟加拉国、巴西、俄罗斯等20多个国家和地区。ANHUI CHEER-OUR MEDICAL TECHNOLOGY CO.,LTD was established in 2015. After continuous aggressive forgenside, it has developed into high -tech pharmaceutical companies that integrate chemistry, biopharmaceutical research, pharmaceutical intermediates, raw materials, preparations and products.Through the development and innovation of medical and health fields such as finished medicines, raw medicines, and intermediates, CHEER-OUR has continuously developed new advantageous varieties with the development trend of synthetic chemical engineering. At present, the main sales markets are more than 20 countries and regions including South Korea, India, Pakistan, Bangladesh, Brazil, and Russia.公司优势:Our advantage:1. 成熟的外贸团队 Mature foreign trade team2. 高水平的工厂支持 High -level factory support3. 优秀的技术团队 Excellent technical team4. 承接CDMO业务 Undertake CDMO business
主要竞争优势
经验丰富的研发人员,发货速度,生产能力,产品线丰富,接受买家的规格要求,接受小额订单,良好的信誉,优质服务
邮政编码
231200
官网地址
www.cheer-our.com
贸易信息
业务类型
代理商,出口商,贸易公司,服务商
主要销售市场
亚洲
主营产品类别
中间体
合同定制与外包服务
CMO/CDMO
参展信息
主营产品
2-Aminoacetophenone(551-93-9);Elagolix(834153-87-6);Sermaglutide(910463-68-2);Rimegepant(1289023-67-1);7,8-dihydro-5H-cyclohepta[b]pyridine-5,9(6H)-dione(39713-40-1);(6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-tetrahydro-9-[[tris(1-methylethyl)silyl]oxy]-5H-cyclohepta[b]pyridin-5-one(1190363-46-2);1-(piperidin-4-yl)-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-one(1209456-28-9);1,3-Dihydro-1-[1-(1H-imidazol-1-ylcarbonyl)-4-piperidinyl]-2H-imidazo[4,5-b]pyridin-2-one(1373116-06-3);Tofacitinib citrate(540737-29-9);4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine(479633-63-1);4-chloro-7H-pyrrolo[2,3-d]pyriMidine(3680-69-1);Pyrrolo[2,3-d]pyrimidin-4-ol(3680-71-5);Tegoprazan(942195-55-3);3-(3,5-DIFLUOROPHENOXY)-PROPANOIC ACID(844648-19-7);5,7-difluorochroman-4-one(844648-22-2);(S)-5,7-difluorochroman-4-ol(942195-91-7);Vonoprazan(881681-00-1);5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde(881674-56-2);2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile(1240948-72-4);Resmetirom(920509-32-6);4-Amino-2,6-dichlorophenol(5930-28-9);3,6-dichloro-4-isopropylpyridazine(107228-51-3);3,6-Dichloropyridazine(141-30-0);N-CYANOACETYLURETHANE(6629-04-5);Lercanidipine hydrochloride(132866-11-6);1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 3-Methyl Ester(74936-72-4);N-Methyl-3,3-diphenylpropylamine hydrochloride(29768-15-8);1-chloro-2-methyl-2-propanol(558-42-9);Posaconazole(171228-49-2);(5R-cis)-Toluene-4-sulfonic acid 5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-yl)methyltetrahydrofuran-3-ylmethyl ester(149809-43-8);2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2,4-Triazol-3-one(184177-83-1);Lumateperone(313368-91-1);(6bR,10aS)-2-oxo-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quin oxaline-8-carboxylic acid ethyl ester(313369-16-3);1-(4-fluorophenyl)-4-((6bs,10ar)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one(313368-92-2);Elobixibat(439087-18-0);2-((3,3-dibutyl-7-(methylthio)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-8-yl)oxy)acetic acid(439088-13-8);(R)-α-[N-(t-butoxycarbonylmethyl) carbamoyl]benzylamine(439088-74-1);Baricitinib(1187594-09-7);Tert-butyl 3-oxoazetidine-1-carboxylate(398489-26-4);4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan- 2-yl)-1H-pyrazole(269410-08-4);Diethyl (cyanomethyl)phosphonate(2537-48-6);4-Chloro-7H-pyrrolo[2,3-d] pyrimidine(3680-69-1);Suzetrigine(2649467-58-1);(5R)-3-(3,4-Difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)-2(5H)-furanone(2875066-35-4);(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxylic acid (R)-1-phenylethan-1-amine salt(2649470-89-1);Methyl 4-aminopyridine-2-carboxylate(71469-93-7);Lenacapavir(2189684-44-2);Carbamic acid, N-[(1S) -1-[3-bromo-6-[3- methyl-3-(methylsulfonyl)-1-butyn-1-yl]-2-pyridinyl]-2-(3,5-difluorophenyl)ethyl]-,1,1-dimethylethyl ester(2189684-54-4);4-Chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)-1-(2,2,2-trifluoroethyl)-1H-indazol 3-amine(2189684-53-3);2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic acid(1620056-83-8)
参展展会
第二十三届世界制药原料中国展
展会时间
2025-03-06至2025-07-31
展位号
E11D06
展品分类
Intermediates & Fine Chemicals
参展信息
×